News
Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
6h
inews.co.uk on MSN1.5m Britons a month pay for weight-loss jabs – and pharmacies ‘ready’ to step upHigh-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...
The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...
Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent of her body weight over 18 months. She was feeling physically better, ...
More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...
4d
US Weekly on MSNEverything Influencer Janelle Rohner Has Said About Weight Loss Before GLP-1 ControversyHealth and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using ...
Get your weekly dose of the top news that matters in our newsletter.
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Cigna, which comprises the Evernorth Health Services division and the Cigna Healthcare insurance business, reported a 19% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results